BCIQ Profiles

Company Profile Report

Cross-border cachet

Vivace’s plans to leverage China-U.S. model to retain more pipeline value

Vivace Therapeutics Inc.’s investors are hoping to leverage the management team’s experience running a U.S.-China cancer company, but this time the goal is to retain more value by advancing the programs into the clinic.

Vivace emerged from stealth mode on June 28

Read the full 422 word article

How to gain access

Continue reading with a
two-week free trial.